Welcome to the resource library, where you can find strategy, research and examples of promising practice in medicine, commissioning and drug services for hepatitis C
Resources
Showing 31 to 40 of 55 resources
-
Blood-borne virus (BBV) testing flash card
This testing flashcard supports the BBV opt-out testing in prisons policy.England May 2014 Training, Tools & Templates PDF -
Information sheet: Useful educational resources to support the opt-out BBV testing policy
England May 2014 Training, Tools & Templates PDF -
EASL Recommendations on Treatment of Hepatitis C: 2014
These EASL Recommendations on Treatment of Hepatitis C are intended to assist physicians and other healthcare providers, as well as patients and other interested individuals, in the clinical decisionmaking process by describing the optimal management of patients with acute and chronic HCV infections. These guidelines apply to therapies that will be approved within less than 6 months at the time of their publication.UK Apr 2014 Reports & Research, Tools & Templates, Strategy & Planning PDF -
World Health Organisation (WHO) Guidelines for the Screening, Care and Treatment of Persons with Hepatitis C Infection
These are the first guidelines dealing with hepatitis C treatment produced by the World Health Organization (WHO) and complement existing guidance on the prevention of transmission of bloodborne viruses, including HCV. They are intended for policy-makers, government officials, and others working in low- and middle income countries who are developing programmes for the screening, care and treatment of persons with HCV infection.Rest of World Apr 2014 Tools & Templates, Strategy & Planning PDF -
EASL Clinical Practice Guidelines: Management of hepatitis C virus infection
These EASL Clinical Practice Guidelines (CPGs) are intended to assist physicians and other healthcare providers, as well as patients and other interested individuals, in the clinical decision-making process by describing the optimal management of patients with acute and chronic HCV infections. These guidelines apply to therapies that are approved at the time of their publication.UK, Rest of World 2014 Training, Reports & Research, Tools & Templates PDF -
Public Health England (PHE) Commissioning template for estimated HCV prevalence and numbers eligible for treatment by Drug Action Team Area (Excel Spreadsheet, 194 KB)This template has been produced by Public Health England (PHE) to help Local Authorities (LA) and Health and Wellbeing Boards estimate the prevalence of hepatitis C virus (HCV) infection in their local population, and the likely disease burden and associated treatment costs.UK 28 Feb 2014 Tools & Templates MS Excel
-
Hepatitis C adult services commissioning toolkit
This toolkit, designed by HCV Action, aims to support commissioners of hepatitis C services to commission for the high level outcomes set out in the new NHS22 and Public Health Outcomes Frameworks:23.UK Sep 2013 Tools & Templates, Strategy & Planning PDF -
The Hepatitis C Adult Services Commissioning Toolkit
This poster, produced by HCV Action, lays out our toolkit for the commissioning of adult services for hepatitis C patients.England 2013 Tools & Templates, Strategy & Planning PDF -
NICE public health guidance 43: Hepatitis B and C - ways to promote and offer testing to people at increased risk of infection
This guidance for commissioners and providers of public services aims to ensure more people at increased risk of hepatitis B and C infection are tested. The recommendations cover awareness-raising; testing; contact tracing; providing and auditing neonatal hepatitis B vaccination; commissioning hepatitis B and C testing and treatment services; and laboratory services for hepatitis B and C testing. This guidance, produced in 2012, was last modified in March 2013.UK Dec 2012 Tools & Templates, Strategy & Planning PDF -
Guidance on testing for hepatitis B and C (with reference to HIV) Developed by Yorkshire and the Humber Hepatitis B and C Steering Group
Individuals with chronic hepatitis (B and C) can be treated, which reduces the likelihood of chronic illness and premature death. Recognition of infection and treatment may also reduce the spread of infection. In 2010 across Yorkshire and the Humber there were 427 cases of hepatitis B (of which 39 were acute) and 980 newly identified hepatitis C infections reported through NHS/HPA laboratory testing, however HPA estimates calculate that there are over 20,000 people actually infected with hepatitis C in the region.Yorkshire and the Humber Mar 2012 Tools & Templates, Strategy & Planning PDF